The institutional investor owned 305,806 shares of the company’s stock after acquiring an additional 7,496 shares during the quarter. Lindbrook Capital LLC now owns 7,574 shares of the company’s stock worth $557,000 after acquiring an additional 141 shares in the last quarter. AstraZeneca PLC has a 52 week low of $61.24 and a 52 week high of $84.61. As a group, sell-side analysts anticipate that AstraZeneca PLC will post 4.51 earnings per share for the current year. Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AstraZeneca PLC (NASDAQ:AZN – Free Report).